Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 15, 2013, after the close
10-K filed Mar 15, 2013, 74 days after period end · 0001144204-13-015444
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $2.50K | — | — |
| Net Income | -$2.71M | -$2.56M | — |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.04 |
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
